CN1562260A - Mediciation for curing female disease - Google Patents
Mediciation for curing female disease Download PDFInfo
- Publication number
- CN1562260A CN1562260A CN 200410023794 CN200410023794A CN1562260A CN 1562260 A CN1562260 A CN 1562260A CN 200410023794 CN200410023794 CN 200410023794 CN 200410023794 A CN200410023794 A CN 200410023794A CN 1562260 A CN1562260 A CN 1562260A
- Authority
- CN
- China
- Prior art keywords
- treatment
- radix
- gynaecopathia
- medicine
- alumen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A Chinese medicine for treating gynopathy, such as acyesis, adnexitis, cervicities, cervical erosion, menalgia, etc is prepared from 18 Chinese-medicinal materials including Chinese angelica root, red peony root, Chuan-xiong rhizome, liquorice root, etc.
Description
Affiliated technical field
The invention belongs to a kind of Chinese medicine for the treatment of gynaecopathia, more precisely is the Chinese medicine pill of treatment gynaecopathia.
Technical background
The disease kind of gynaecopathia is a lot, as sterility, menoxenia, puerperal exposure to wind, puerperal lumbago and skelalgia, amenorrhea, through come abdomen painful, in vain stagnate red down, pelvic inflammatory disease, cervicitis, vaginitis, cervical erosion etc., gynaecopathia has brought inconvenience for comrade women in daily life, harm women physical and mental health.Gynaecopathia is medically thought in motherland, belongs to the endogenous cause of ill phlegm-damp, exopathogenic factor wind and cold, and stagnation of QI due to depression of the liver, the cold leukorrhagia that stagnates, how by strongly fragrant in the QI and blood, functional activity of QI being not smooth, blood stasis due to qi deficiency.Defectives such as at present, the drug variety of treatment gynaecopathia is a lot, but exists the treatment unicity, and curative effect is slow, and cure rate is lower.
Summary of the invention
The purpose of this invention is to provide a kind of extensive, that cure rate is high, curative effect is fast a kind of medicine (the clean ball in palace) for the treatment of gynaecopathia for the treatment of.
Technical solution of the present invention is:
The medicine (the clean ball in palace) of this kind treatment gynaecopathia is characterized in that it is made up of 18 kinds of pure Chinese medicines: Radix Angelicae Sinensis 150g, Cortex Phellodendri 100g, Radix Paeoniae Rubra 100g, pollen 100g, Rhizoma Chuanxiong 100g, Radix Glycyrrhizae 80g, Flos Carthami 50g ， Zhu sand 50g, Alumen 40g, Radix Aucklandiae 40g, purple brain sand 35g, dried Alumen 30g, BAINAOSHA 30g, Borneolum Syntheticum 30g, Rhizoma Atractylodis 30g, Sanguis Draxonis 20g, Realgar 10g, Epicauta gorhami 5g amounts to 1000g, grinds to the powder, grind to the powder, cross 100 mesh sieves, honey is transferred the spiral ball, every ball 10g is wrapped up in the two-layer vagina cervix uteri mouth place of inserting outward with antiseptic gauze, takes out in 3rd, eliminating cold for resuscitation water is rinsed well and is got final product, and belongs to medicine for external use.According to the size of dosage, prepare according to the above ratio.
The invention has the beneficial effects as follows:
Pharmacology analysis: sensible, invigorate blood circulation, blood stasis dispelling, tissue regeneration promoting, removing dampness, detoxifcation.
This root is controlled the intractable infertility, and leucorrhea, adnexitis, cervicitis, cervical erosion, dysmenorrhea, vicarious menstruation, menoxenia, metrorrhagia, pelvic inflammatory disease, obstruction of fallopian tube, vaginitis, habitual abortion etc. are had unique curative effect.In 1 hundred 60 practice is cured case and is reached tens0000 examples, has no side effect, and takes place from none routine contingency.Through the relevant expert of city institute of traditional Chinese medicine clinical trial, effect spy is good.
Clinical case is as follows:
Wang Qian suffers from pelvic inflammatory disease 40 years old in January, 99, at many places hospitalize, DeGrain.Use this pill 3 balls, recovery from illness.
Bright flourish 35 years old adnexitis of Lee do not heal for many years, uses the recovery from illness of this pill 2 balls.
30 years old gynaecological disease of Cui Ying, frequent lumbago, menstruation is inaccurate, and leucorrhea is many, and not healing in the Changzhi, uses this pill 3 balls, recovery from illness.
38 years old cervicitis of Zhang Siyi do not heal for many years, uses the recovery from illness of this pill 4 balls.
The clinical sight of this pill treatment gynaecopathia 100 routine curative effects comes to an end really as follows:
Purpose: understand this pill clinical therapeutic efficacy;
Method: adopt the stochastic sampling double-blind method to observe therapeutic effect and the safety thereof of Chinese medicine pill to 100 routine gynaecopathia patients.
Conclusion: clinical therapeutic efficacy of the present invention is good, and safety is good, and is easy to use, does not find any side effect in clinical.
1, material method
1,1 object of observation
Medication same period patient 100 examples, age 20-55 year, vaginitis 20 examples wherein, adnexitis 20 examples, pelvic inflammatory disease 20 examples, cervical erosion 20 examples, menoxenia, dysmenorrhea 20 examples.
1,2 therapeutic regimens
Full group patient is divided into treatment at random by double-blind method and organizes 100 examples, and the treatment group gives clinical treatment of the present invention, uses per three days one balls of this medicine.
1,3 sees checking method
All all write down medical history before every routine patient, sign, diagnosis, painful area and character and relevant physics, physiology inspection.
1,4 therapeutic effect are observed
Patient is to serve as treatment observing time 4 courses of treatment (12 days).
Criterion of therapeutical effect:
A, invalid: the treatment back does not have change with treatment state of an illness symptom.
B, effective: treatment back state of an illness sign has improvement.
C, produce effects: treatment back state of an illness sign has clear improvement.
D, recovery from illness: treatment back disease all disappears, and reaches the clinical cure standard.
1,5 treatments are analyzed
All clinical datas behind finishing analysis with the treatment group invalid, effectively, produce effects, four standards of fully recover are judged comparison, look into the significance of its difference by the statistical procedures sight.
2 results
2,1 curative effect
Use the present invention's 100 example treatment gynaecopathia patient efficacy results
(seeing Table 1)
Table 1
| Diagnosis | The example number | Curative effect | |||
| Invalid | Effectively | Produce effects | Recovery from illness | ||
| Vaginitis | ????20 | ????1 | ????19 | ||
| Adnexitis | ????20 | ????1 | ????1 | ????18 | |
| Pelvic inflammatory disease | ????20 | ????1 | ????2 | ????17 | |
| Cervical erosion | ????20 | ????2 | ????18 | ||
| The menoxenia dysmenorrhea | ????1 | ????1 | ????18 | ||
| Subtotal | ????1 | ????4 | ????5 | ????90 | |
100 routine patient treatment curative effect statistics (seeing Table 2)
| Group | The example number | Curative effect | |||
| Invalid % | Effective % | Produce effects % | Recovery from illness % | ||
| Treatment group of the present invention | ??100 | ????1 | ????4 | ????5 | ????90 |
Total effective rate reaches 99%.Compare with conventional medicament, the present invention treats the gynaecopathia wide ranges, and curative effect is fast, the cure rate height.
2.2 toxic and side effects
100 examples are used none example of patient of the present invention and discomfort, toxic and side effects such as swelling are occurred.Experimental check hematuria, just conventional, all no abnormal change of liver, renal function.Pointing out the present invention thus is safety medicine for external use without any side effects.
The specific embodiment
Prescription: Radix Angelicae Sinensis 150g, Cortex Phellodendri 100g, Radix Paeoniae Rubra 100g, pollen 100g, Rhizoma Chuanxiong 100g, Radix Glycyrrhizae 80g, Flos Carthami 50g Zhu sand 50g, Alumen 40g, Radix Aucklandiae 40g, purple brain sand 35g, dried Alumen 30g, BAINAOSHA 30g, Borneolum Syntheticum 30g, Rhizoma Atractylodis 30g, Sanguis Draxonis 20g, Realgar 10g, Epicauta gorhami 5g amounts to 1000g.
Get above-mentioned raw materials, grind to the powder, cross 100 mesh sieves, honey is transferred the spiral ball, and every ball 10g is wrapped up in the two-layer vagina cervix uteri mouth place of inserting outward with antiseptic gauze, takes out in 3rd, and eliminating cold for resuscitation water is rinsed well and got final product, and belongs to medicine for external use.
Claims (1)
- A kind of medicine (the clean ball in palace) for the treatment of gynaecopathia is characterized in that it is made up of 18 kinds of pure Chinese medicines: Radix Angelicae Sinensis 150g, Cortex Phellodendri 100g, Radix Paeoniae Rubra 100g, pollen 100g, Rhizoma Chuanxiong 100g, Radix Glycyrrhizae 80g, Flos Carthami 50g Zhu sand 50g, Alumen 40g, Radix Aucklandiae 40g, purple brain sand 35g, dried Alumen 30g, BAINAOSHA 30g, Borneolum Syntheticum 30g, Rhizoma Atractylodis 30g, Sanguis Draxonis 20g, Realgar 10g, Epicauta gorhami 5g, amount to 1000g, grind to the powder, honey is transferred the spiral ball.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410023794 CN1279953C (en) | 2004-04-07 | 2004-04-07 | Mediciation for curing female disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410023794 CN1279953C (en) | 2004-04-07 | 2004-04-07 | Mediciation for curing female disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1562260A true CN1562260A (en) | 2005-01-12 |
| CN1279953C CN1279953C (en) | 2006-10-18 |
Family
ID=34480324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410023794 Expired - Fee Related CN1279953C (en) | 2004-04-07 | 2004-04-07 | Mediciation for curing female disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1279953C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101502634B (en) * | 2009-03-06 | 2011-11-02 | 陈殿红 | Chinese medicinal composition for treating uterine blood flow and preparation method thereof |
| CN104800815A (en) * | 2015-05-15 | 2015-07-29 | 秦炜萍 | Traditional Chinese medicine preparation for treating vicarious menstruation |
| CN107158332A (en) * | 2017-07-14 | 2017-09-15 | 贾凤仙 | A kind of medicine pill for treating women's genital system diseases |
-
2004
- 2004-04-07 CN CN 200410023794 patent/CN1279953C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101502634B (en) * | 2009-03-06 | 2011-11-02 | 陈殿红 | Chinese medicinal composition for treating uterine blood flow and preparation method thereof |
| CN104800815A (en) * | 2015-05-15 | 2015-07-29 | 秦炜萍 | Traditional Chinese medicine preparation for treating vicarious menstruation |
| CN104800815B (en) * | 2015-05-15 | 2018-07-20 | 秦炜萍 | A kind of Chinese medicine preparation for treating vicarious menstruation disease |
| CN107158332A (en) * | 2017-07-14 | 2017-09-15 | 贾凤仙 | A kind of medicine pill for treating women's genital system diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1279953C (en) | 2006-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101461911B (en) | Chinese medicine oral capsule for treating gout | |
| CN101049415A (en) | Preparation of Chinese traditional medicine for treating inflammation of department of gynecology | |
| CN102247581B (en) | Medicament for treating myoma of uterus | |
| CN100548354C (en) | A kind of oral liquid for the treatment of nephropathy | |
| CN1966052A (en) | Tablet containing red sage root and astragalus root for removing blood stasis and preparation process thereof | |
| CN102631641A (en) | Clysis liquid for treating pelvic inflammation | |
| CN104771671A (en) | Traditional Chinese medicine lotion for treating gynecological inflammation | |
| CN1279953C (en) | Mediciation for curing female disease | |
| CN1843421A (en) | Rheumatoid disease treating medicine | |
| CN1325096C (en) | Chinese medicine formulation for treating ance disease | |
| CN1086297C (en) | A Chinese medicinal pill for treating gynecological diseases | |
| CN1265818C (en) | Leech capsule | |
| CN1765381A (en) | Conditioning qi-invigorating weight-reducing extract | |
| CN104800675A (en) | Medicament for treating active ulcerative colitis | |
| CN1778363A (en) | Medicine for treating gynecopathy | |
| CN1682915A (en) | Medicine for treating pelvic inflammation and preparation method thereof | |
| CN104013718A (en) | Field thistle decoction traditional Chinese medicine preparation | |
| CN103349767B (en) | Inula nervosa Wall oil capsule preparation and preparation method thereof | |
| CN1299726C (en) | Pregnancy promoting pill | |
| CN118717900A (en) | Traditional Chinese medicine composition for assisting acupuncture and moxibustion in treating heat stranguria | |
| CN1682859A (en) | Chinese medicine for treating rhinitis | |
| CN1565500A (en) | Chinese traditional medicine for treating thyroid malignant tumor | |
| CN118477131A (en) | Chinese medicinal capsule for preventing and treating calculus | |
| CN104666651A (en) | Agent for treating cervical hypertrophy | |
| CN102512637B (en) | Medicine for treating special chronic sinusitis of patients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20061018 Termination date: 20120407 |